https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-05-16 / 2019 May;19(1):460
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-05-16 / 2019 May;19(1):4602019-05-16 00:00:002020-10-05 10:19:52Phase I study of high-dose ascorbic acid with mFOLFOX6 or FOLFIRI in patients with metastatic colorectal cancer or gastric cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-01-12 / Life Sci. 2019 Feb;219:136-143
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-01-12 / Life Sci. 2019 Feb;219:136-1432019-01-12 00:00:002019-01-12 00:00:00Induction of T cell-mediated immune response by dendritic cells pulsed with mRNA of sphere-forming cells isolated from patients with gastric cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2018-12-04 / Clin. Cancer Res. 2019 Mar;25(5):1494-1504
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2018-12-04 / Clin. Cancer Res. 2019 Mar;25(5):1494-15042018-12-04 00:00:002018-12-04 00:00:00Autologous Dendritic Cell-Cytokine Induced Killer Cell Immunotherapy Combined with S-1 Plus Cisplatin in Patients with Advanced Gastric Cancer: A Prospective Study
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2018-11-01 / Anticancer Res. 2018 Nov;38(11):6561-6564
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2018-11-01 / Anticancer Res. 2018 Nov;38(11):6561-65642018-11-01 00:00:002018-11-01 00:00:00Case Report of a Patient with Breast Metastasis from Gastric Cancer Treated with Paclitaxel and Ramucirumab Plus Regional Hyperthermia
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-05-27 / Onco Targets Ther 2015;8:1265-70
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-05-27 / Onco Targets Ther 2015;8:1265-702015-05-27 00:00:002015-05-27 00:00:00Hyperthermia combined with 5-fluorouracil promoted apoptosis and enhanced thermotolerance in human gastric cancer cell line SGC-7901
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-05-21 / World J. Gastroenterol. 2015 May;21(19):5778-93
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-05-21 / World J. Gastroenterol. 2015 May;21(19):5778-932015-05-21 00:00:002015-05-21 00:00:00Gastric cancer and the epoch of immunotherapy approaches
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-04-03 / PLoS ONE 2014;9(4):e93886
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-04-03 / PLoS ONE 2014;9(4):e938862014-04-03 00:00:002019-02-15 08:46:18Autologous tumor lysate-pulsed dendritic cell immunotherapy with cytokine-induced killer cells improves survival in gastric and colorectal cancer patients
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-08-07 / J. Huazhong Univ. Sci. Technol. Med. Sci. 2011 Aug;31(4):488
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-08-07 / J. Huazhong Univ. Sci. Technol. Med. Sci. 2011 Aug;31(4):4882011-08-07 00:00:002011-08-07 00:00:00Synergistic effect of hyperthermia and neferine on reverse multidrug resistance in adriamycin-resistant SGC7901/ADM gastric cancer cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-06-01 / J. Mol. Med. 2010 Jun;88(6):589-96
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-06-01 / J. Mol. Med. 2010 Jun;88(6):589-962010-06-01 00:00:002010-06-01 00:00:00Antitumor efficacy of viral therapy using genetically engineered Newcastle disease virus [NDV(F3aa)-GFP] for peritoneally disseminated gastric cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-08-01 / Int J Hyperthermia 2008 Aug;24(5):399-408
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-08-01 / Int J Hyperthermia 2008 Aug;24(5):399-4082008-08-01 00:00:002008-08-01 00:00:00Regional hyperthermia of the abdomen in conjunction with chemotherapy for peritoneal carcinomatosis: evaluation of two annular-phased-array applicators
